(S)-3-(4-Bromophenyl)-2-hydroxypropanoic acid, 95%, 1g

1-((2R,4S,5R)-4-((TRIETHYLSILYL)OXY)-5-(((TRIETHYLSILYL)OXY)METHYL)TETRAHYDROFURAN-2-YL)-5-VINYLPYRIMIDINE-2,4(1H,3H)-DIONE, 95%, 50mg

(1-ethyl-1H-benzimidazol-2-yl)methanol, 95.0%, 1g

5-Pyrimidinecarboxamide, N-hydroxy-2-[(1-phenylcyclopropyl)amino]-, 25mg

1-Methyl-1h,2h,3h-imidazo[4,5-c]pyridin-2-one, 98%, 500mg

IMIDAZO[2,1-F][1,2,4]TRIAZIN-4-OL, 97.0%, 1g

(2-Aminopyridin-3-yl)methyl tert-butyl carbonate, 97.0%, 1g

1-(Dimethylethylsilyl)imidazole [Dimethylethylsilylating Agent]>98.0%(T)1g

Accouplement à vis, GL 25, 1 pièce

(S)-(1,4-OXAZEPAN-2-YL)METHANOL HCL, 95.0%, 100mg

N,N-Diisopropylethylenediamine>97.0%(GC)(T)500mL

1-(3-Bromophenyl)-2-(methylamino)ethan-1-ol, 95%, 1g

4-(2-Methyltetrahydro-2H-pyran-4-yl)-pyridine, 1g